Flagship Pioneering’s Lila Sciences has landed a substantial $235 million series A as it looks to exceed the current limits ...

Government-funded academic research (GoFAR), lately the subject of across-the-board cuts in the U.S., is one of the engines ...

The study will interest researchers studying genome organisation in mitosis. Genomes assume a complex 3D architecture in the interphase cell nucleus. Yet, the molecular mechanisms that determine ...

If you have been watching CRISPR Therapeutics (CRSP) lately, you have probably noticed the sharp rebound in its stock price. The rally was set off by compelling developments, specifically Casgevy’s ...

Shares of CRISPR Therapeutics CRSP have rallied 41.4% in the past three months, driven by encouraging data from a study of its in-vivo candidate, CTX310, as well as better-than-expected sales of ...

NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...

Young people entering classrooms this fall need a totally different tool set than the generations before them.

While biotech hubs like Boston, San Francisco, San Diego and Raleigh-Durham, North Carolina, are home to thousands of ...

Cathie Wood’s ARK ETFs have reported their daily trades for Tuesday, August 26th, 2025, with significant activity in biotech and tech stocks. The largest trade of the day was the purchase of 165,874 ...

As the Digital Age evolves, savvy investors are turning to deep technologies like revolutionary materials and programmable ...